Date | Price Target | Rating | Analyst |
---|---|---|---|
1/12/2024 | $6.50 → $4.00 | Overweight → Underweight | Barclays |
11/14/2023 | $7.00 → $6.50 | Equal Weight → Overweight | Barclays |
5/18/2023 | Buy → Neutral | BofA Securities | |
6/1/2022 | $12.00 | Equal Weight | Barclays |
2/14/2022 | $9.00 → $10.00 | Equal-Weight | Morgan Stanley |
12/6/2021 | $7.00 → $9.00 | Equal-Weight | Morgan Stanley |
Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously
Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously
BofA Securities downgraded ICL Group from Buy to Neutral
Growing Solutions signs agreement with AMP Holdings Group for specialty water soluble fertilizers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a five-year agreement with AMP Holdings Group Co. Ltd., one of China's top agricultural distribution companies. The agreement, valued at approximately $170 million, will run until 2028 and advances ICL's stated goal to expand its Growing Solutions product offerings and to position the business for further growth in major end-markets. The agreement is for specialty water soluble fertilizers, which are used in drip irrigation and designed for cash-crops, such as apples, watermelons, vegetabl
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief technology and innovation officer for ICL, will be presenting at Jefferies 2024 Industrials Conference at 8:40 a.m. ET on Wednesday, September 4, 2024. A webcast of the event will be available at https://investors.icl-group.com/reports-news-and-events/default.aspx#events-presentations. A replay will be available at the same site for a limited time, following the live event. About ICL ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and ind
TEL AVIV, Israel, Aug. 15, 2024 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2024. Selected Financial Figures for the Second Quarter 2024: $m Q2/24 Q2/23 ILCO share in ICL profit1 49 72 Financing, G&A and other expenses at ILCO headquarter level (1) (2) Tax income of ILCO Headquarters - - Net profit to company's shareholders 48 70 Liquidity at the ILCO Headquarters Level2As of June 30, 2024, total financial liabilities were $754 million, and investments in liquid assets amounted to $858 million of which $163 million are pledged deposits. Net cash1 as of June 30, 2024, totaled $64 million. The ne
6-K - ICL Group Ltd. (0000941221) (Filer)
6-K - ICL Group Ltd. (0000941221) (Filer)
6-K - ICL Group Ltd. (0000941221) (Filer)
Expanded Board Enhances Financial and Governance Expertise Supporting ESG Commitments REE Automotive Ltd. (NASDAQ:REE), a leader in e-mobility, announced today that it has expanded its Board of Directors, appointing two new independent members. The additional board members deepen and diversify its leadership as the company progresses towards technology maturation and commercial production in 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026005784/en/Michal Brikman (Photo: Business Wire) REE has appointed seasoned veterans Ms. Michal Brikman and Ms. Lilach Geva-Harel, who bring a wealth of public company financial, corp
TEL AVIV, Israel, Aug. 15, 2024 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2024. Selected Financial Figures for the Second Quarter 2024: $m Q2/24 Q2/23 ILCO share in ICL profit1 49 72 Financing, G&A and other expenses at ILCO headquarter level (1) (2) Tax income of ILCO Headquarters - - Net profit to company's shareholders 48 70 Liquidity at the ILCO Headquarters Level2As of June 30, 2024, total financial liabilities were $754 million, and investments in liquid assets amounted to $858 million of which $163 million are pledged deposits. Net cash1 as of June 30, 2024, totaled $64 million. The ne
Continued to deliver sequential growth, with sales of $1.8 billion, operating income of $211 million and adjusted EBITDA of $377 million Raising guidance for specialties-driven businesses ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2024. Consolidated sales were $1.75 billion versus $1.87 billion in the prior year. Operating income was $211 million, with adjusted operating income of $225 million, versus $300 million of operating income in the second quarter of last year. Adjusted EBITDA was $377 million versus $441 million. Diluted earnings per share were $0.09, with adjusted diluted E
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2024 results prior to the opening of the TASE market on Wednesday, August 14, 2024. On that day, Raviv Zoller, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). Analysts are invited to pre-register for the call, in advance, at https://investors.icl-group.com/reports-news-and-events/#events-presentations. Employees, the media and the public are also invited to join the call online. A replay
SC 13G - ICL Group Ltd. (0000941221) (Subject)
SC 13G/A - ICL Group Ltd. (0000941221) (Subject)
SC 13G/A - ICL Group Ltd. (0000941221) (Subject)
More than one dozen novel microbes identified for row crops suffering from extreme weather conditionsTEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown und
ICL Group (NYSE:ICL) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 60.87 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $1.735 billion which missed the analyst consensus estimate of $1.752 billion by 0.95 percent. This is a 18.01 percent decrease over sales of $2.116 billion the same period last year.
Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:ICL) with a Underweight and raises the price target from $4 to $4.5.